![Kristin Abate](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kristin Abate
Comptroller/Controller/Revisor på
KARYOPHARM THERAPEUTICS INC.
Förmögenhet: 48 991 $ per 2026-08-31
Profil
Kristin Abate is currently Chief Accounting Officer & Executive VP at Karyopharm Therapeutics, Inc., a position held since 2025.
Education includes graduate studies at Boston College and undergraduate studies at Bryant University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-01 | 23 782 ( 0,1 % ) | 48 991 $ | 2026-08-31 |
Aktiva positioner av Kristin Abate
| Företag | Position | Start |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Comptroller/Controller/Revisor | 2019-07-01 |
Kristin Abates utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
45
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bryant University
 Bryant University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karyopharm Therapeutics, Inc.
 Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
